Lipopolysaccharide-Induced TNF Factor Protein

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
LITAF is a recombinant protein.
Documents del producto
Product specifications
Category | Proteins and Peptides |
Immunogen Target | LITAF |
Conjugation | Unconjugated |
Expression | Recombinant |
Purity | > 85% (SDS-PAGE) |
Size 1 | 5 µg |
Size 2 | 20 µg |
Size 3 | 1 mg |
Form | Liquid |
Tested Applications | SDS-PAGE |
Availability | Shipped within 5-10 working days. |
Dry Ice | No |
UniProt ID | Q99732 |
Background | Protein LITAF |
Status | RUO |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human LITAF (Lipopolysaccharide-induced tumor necrosis factor-alpha factor) ELISA Kit
Ver Producto
Mouse LITAF (Lipopolysaccharide-induced tumor necrosis factor-alpha factor) ELISA Kit
Ver Producto
LITAF antibody
Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene.
Ver Producto